Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7328576rdf:typepubmed:Citationlld:pubmed
pubmed-article:7328576lifeskim:mentionsumls-concept:C0016360lld:lifeskim
pubmed-article:7328576lifeskim:mentionsumls-concept:C0040085lld:lifeskim
pubmed-article:7328576lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:7328576lifeskim:mentionsumls-concept:C1704675lld:lifeskim
pubmed-article:7328576lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:7328576pubmed:issue10lld:pubmed
pubmed-article:7328576pubmed:dateCreated1982-4-20lld:pubmed
pubmed-article:7328576pubmed:abstractTextA number of 1-(5-phospho-beta-D-arabinosyl)-5-substituted-uracils (ara-UMP's) have been examined as inhibitors of dTMP synthetase. As reversible inhibitors, all were substantially less potent than their 2'-deoxyribosyl counterparts. In the presence of 5,10-methylenetetrahydrofolate (CH2-H4folate), ara-FUMP caused a first-order, time-dependent inactivation of the enzyme. At 0 degrees C, kinetic studies indicated a reversible Kd of 3.6 micro M for the ara-FUMP-CH2-H4folate complex, and k = 0.22 min-1 for the subsequent inactivation. Spectral studies of the complex and its behavior toward protein denaturants demonstrate that its structure and stoichiometry are directly analogous to those which have previously been described for FdUMP. The significance of this finding with regard to prodrugs of ara-FU and the potential of ara-FU as a chemotherapeutic agent are discussed.lld:pubmed
pubmed-article:7328576pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7328576pubmed:languageenglld:pubmed
pubmed-article:7328576pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7328576pubmed:citationSubsetIMlld:pubmed
pubmed-article:7328576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7328576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7328576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7328576pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7328576pubmed:statusMEDLINElld:pubmed
pubmed-article:7328576pubmed:monthOctlld:pubmed
pubmed-article:7328576pubmed:issn0022-2623lld:pubmed
pubmed-article:7328576pubmed:authorpubmed-author:NakayamaCClld:pubmed
pubmed-article:7328576pubmed:authorpubmed-author:UedaTTlld:pubmed
pubmed-article:7328576pubmed:authorpubmed-author:SaneyoshiMMlld:pubmed
pubmed-article:7328576pubmed:authorpubmed-author:SantiD VDVlld:pubmed
pubmed-article:7328576pubmed:authorpubmed-author:WatayaYYlld:pubmed
pubmed-article:7328576pubmed:issnTypePrintlld:pubmed
pubmed-article:7328576pubmed:volume24lld:pubmed
pubmed-article:7328576pubmed:ownerNLMlld:pubmed
pubmed-article:7328576pubmed:authorsCompleteYlld:pubmed
pubmed-article:7328576pubmed:pagination1161-5lld:pubmed
pubmed-article:7328576pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:7328576pubmed:meshHeadingpubmed-meshheading:7328576-...lld:pubmed
pubmed-article:7328576pubmed:meshHeadingpubmed-meshheading:7328576-...lld:pubmed
pubmed-article:7328576pubmed:meshHeadingpubmed-meshheading:7328576-...lld:pubmed
pubmed-article:7328576pubmed:meshHeadingpubmed-meshheading:7328576-...lld:pubmed
pubmed-article:7328576pubmed:meshHeadingpubmed-meshheading:7328576-...lld:pubmed
pubmed-article:7328576pubmed:meshHeadingpubmed-meshheading:7328576-...lld:pubmed
pubmed-article:7328576pubmed:year1981lld:pubmed
pubmed-article:7328576pubmed:articleTitleInteraction of 1-(5-phospho-beta-D-arabinofuranosyl)-5-substituted-uracils with thymidylate synthetase: mechanism-based inhibition by 1-(5-phospho-beta-D-arabinosyl)-5-fluorouracil.lld:pubmed
pubmed-article:7328576pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7328576pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:7328576lld:chembl
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7328576lld:pubmed